Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study by van Hecke, Oliver et al.
RESEARCH ARTICLE
Chronic pain, depression and cardiovascular
disease linked through a shared genetic
predisposition: Analysis of a family-based
cohort and twin study
Oliver van Hecke1☯¤, Lynne J. Hocking2,3☯, Nicola Torrance1, Archie Campbell3,
Sandosh Padmanabhan3,4, David J. Porteous3,5, Andrew M. McIntosh3,6, Andrea
V. Burri7,8,9, Haruka Tanaka10, Frances M. K. Williams9, Blair H. Smith1,3*
1 Division of Population Health Sciences, School of Medicine, University of Dundee, Dundee, United
Kingdom, 2 Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom, 3 Generation
Scotland, Centre for Genomics and Experimental Medicine, Institute of Genetics & Molecular Medicine,
University of Edinburgh, Edinburgh, United Kingdom, 4 Institute of Cardiovascular and Medical Sciences,
University of Glasgow, Glasgow, United Kingdom, 5 Centre for Genomics and Molecular Medicine, Institute
of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom, 6 Division of
Psychiatry, University of Edinburgh, Edinburgh, United Kingdom, 7 Institute of Psychology, University of
Zurich, Zurich, Switzerland, 8 Faculty of Health and Environmental Sciences, Auckland University of
Technology, Auckland, New Zealand, 9 Dept of Twin Research and Genetic Epidemiology, King’s College
London, London, United Kingdom, 10 Mie Prefectural College of Nursing, Tsu, Mie, Japan
☯ These authors contributed equally to this work.
¤ Current address: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford,
United Kingdom
* b.h.smith@dundee.ac.uk
Abstract
Background
Depression and chronic pain are the two most important causes of disability (Global Burden
of Disease Study 2013). They occur together more frequently than expected and both condi-
tions have been shown to be co-morbid with cardiovascular disease. Although shared
socio-demographic risk factors (e.g. gender, deprivation) might explain the co-morbidity of
these three conditions, we hypothesised that these three long-term, highly prevalent condi-
tions co-occur and may be due to shared familial risk, and/or genetic factors.
Methods and findings
We employed three different study designs in two independent cohorts, namely Generation
Scotland and TwinsUK, having standardised, validated questionnaire data on the three traits
of interest. First, we estimated the prevalence and co-occurrence of chronic pain, depression
and angina among 24,024 participants of a population-based cohort of extended families
(Generation Scotland: Scottish Family Health Study), adjusting for age, gender, education,
smoking status, and deprivation. Secondly, we compared the odds of co-morbidity in sibling-
pairs with the odds in unrelated individuals for the three conditions in the same cohort. Lastly,
examination of similar traits in a sample of female twins (TwinsUK, n = 2,902), adjusting for
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age and BMI, allowed independent replication of the findings and exploration of the influence
of additive genetic (A) factors and shared (C) and non-shared (E) environmental factors pre-
disposing to co-occurring chronic widespread pain (CWP) and cardiovascular disease (hyper-
tension, angina, stroke, heart attack, elevated cholesterol, angioplasty or bypass surgery). In
the Generation Scotland cohort, individuals with depression were more than twice as likely to
have chronic pain as those without depression (adjusted OR 264 [95% CI 234–297]); those
with angina were four times more likely to have chronic pain (OR 419 [364–482]); those with
depression were twice as likely to have angina (OR 220 [190–254]). Similar odds were
obtained when the outcomes and predictors were reversed and similar effects seen among
sibling pairs; depression in one sibling predicted chronic pain in the other (OR 134 [105–
171]), angina predicted chronic pain in the other (OR 219 [163–295]), and depression,
angina (OR 198 [149–265]). Individuals with chronic pain and angina showed almost four-
fold greater odds of depression compared with those manifesting neither trait (OR 378 [299–
478]); angina showed seven-fold increased odds in the presence of chronic pain and depres-
sion (OR 776 [605–995]) and chronic pain nine-fold in the presence of depression and
angina (OR 943 [685–1298]). In TwinsUK, the relationship between CWP and depression
has been published (R = 0.34, p<0.01). Considering the CWP-cardiovascular relationship, the
most suitable model to describe the observed data was a combination of A, C and E, with a
small but significant genetic predisposition, shared between the two traits (22% [95% CI
006–023]).
Conclusion
We found an increased co-occurrence of chronic pain, depression and cardiovascular dis-
ease in two independent cohorts (general population-based cohort, twins cohort) suggesting
a shared genetic contribution. Adjustment for known environmental influences, particularly
those relating to socio-economic status (Generation Scotland: age, gender, deprivation,
smoking, education; Twins UK: age,BMI) did not explain the relationship observed between
chronic pain, depression and cardiovascular disease. Our findings from two independent
cohorts challenge the concept of traditional disease boundaries and warrant further investi-
gation of shared biological mechanisms.
Introduction
The prevalence of painful conditions co-occurring with other chronic diseases has been
under-recognised until recently [1, 2]. For example, chronic pain is common, affecting
approximately 1 in 5 adults in the general population across Europe [3]. Chronic pain with
sleep disturbance [4] shows a strong association with anxiety and depression [5] and longitudi-
nal studies suggest the associated overall disease burden among individuals with co-morbidi-
ties, co-prescribing and co-occurrence of disability all lead to greater challenges in managing
each condition in turn [6].
Observational evidence suggests some form of co-occurrence between chronic pain,
depression and/or cardiovascular disease and associated poor health and premature death [2].
This is supported by good bi-directional evidence linking chronic pain and depression [7, 8],
depression and cardiovascular disease [9–11], and to a lesser extent, chronic pain and
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cardiovascular disease [12]. However we are less sure the extent to which one condition is
driven by one (or multiple) condition(s), whether co-morbid conditions share a common aeti-
ology, or whether they occur independently.
This co-occurrence of conditions may be related to alterations in the stress-response system
[13], and/or metabolic or inflammatory processes [14], or for other reasons yet to be defined,
such as genetic predisposition [15]. Because of the complexity of the pain experience and its
multi-factorial effect on health-related quality of life, it remains unclear the extent to which the
clustering of chronic pain, depression and cardiovascular disease in individuals is the result of
a shared aetiology, and/or modifying or confounding factors such as health inequality, as all
three conditions are associated with indicators of (relative) deprivation [16].
In this study, we firstly aimed to quantify the likelihood of these conditions co-occurring in
a large general population-based cohort, secondly to ascertain whether this may be due in part
to shared familial risk, and finally to confirm findings in a UK twin cohort.
Methods
Overall study population and participants
Generation Scotland. Data were obtained from Generation Scotland: Scottish Family
Health Study (GS:SFHS; www.generationscotland.org) [17], a large general population-based
cohort (n = 24,042) of extended families recruited across Scotland during 2006–2011.
Data on chronic pain, cardiovascular and mental health variables including depression
were collected at the initial study visit by validated self-completed questionnaires and a clinic-
based examination. Socio-demographic data included age at assessment, gender, educational
attainment and smoking status, and the Scottish Index of Multiple Deprivation 2009 (SIMD),
based on residential postcode. SIMD is grouped into quintiles ranking those areas from most
deprived (ranked 1) to least deprived (ranked 5) [18]. Participants were unaware of the current
study aims. A detailed description of GS:SFHS, including recruitment, data collection and
baseline epidemiology, has been published previously [19].
TwinsUK. The replication sample was drawn from the TwinsUK registry (www.twinsuk.
ac.uk), which has been shown to be representative and comparable to the general population
in terms of behavior, lifestyle factors and diseases [20]. Detailed information on the twin
cohort has been published elsewhere [21, 22]. Because of the very small number of males with
data on CWP and to avoid gender as an additional confounding variable, only females were
included in the sample. Zygosity was confirmed by genotyping [23]. A total of 2,902 female
twins aged 17 years, comprising 749 monozygotic (MZ) twin pairs and 702 same-sex dizy-
gotic (DZ) twin pairs were included in this study. Collection of chronic pain phenotypes and
genetic information (from blood samples) was carried out during clinical visits and via postal
questionnaires. The twin subjects were unaware of the research interests of the present study.
Variables
Chronic pain. In the GS:SFHS cohort, chronic pain was defined as reported pain or dis-
comfort persisting longer than 3 months [24], identified by a validated questionnaire [25],
and included the body site(s) affected and site of worst pain [26, 27].The Chronic Pain Grade
(CPG) questionnaire was used to assess pain severity based on intensity and pain-related disabil-
ity in the previous three months [28]. The CPG is a 7-item instrument that classifies severity into
four hierarchical grades: Grade I (low disability-low intensity), Grade II (low disability-high
intensity), Grade III (high disability-moderately limiting) and Grade IV (high disability-severely
limiting. We defined clinically significant chronic pain as those with CPG II-IV, representing
those with high pain intensity and/or high pain-related disability. “Chronic pain controls” were
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those who reported no current pain or discomfort. Participants with non-chronic pain or CPG I
were excluded from analyses.
In TwinsUK, the London Fibromyalgia Epidemiology Symptom Screening Questionnaire
(LFESSQ) was used to screen for self-reported chronic widespread pain (CWP)[29]. This ques-
tionnaire includes four items relating to widespread pain (and two items relating to fatigue).
We assessed CWP according to the four items pertaining to the “pain subscale; asking about
pain on the left and right sides of body and above and below the diaphragm, and lasting at
least seven days in the previous three months. In order to be classified as having CWP, partici-
pants had to respond “yes” to all four pain items demonstrating pain on both sides of the body
and above and below the diaphragm. This phenotype definition is supported by the contribu-
tion this sample has made to previous large studies [30, 31].
Depression. All participants in GS:SFHS who attended the research clinic (n = 21,473)
were screened for a history of emotional and psychiatric disorders using two questions from
the Structured Clinical Interview for DSM-IV Disorders (SCID)[32], a validated instrument
for detecting a lifetime history of mental illness. Those who screened positively were invited to
complete the full SCID interview conducted face-to-face by a trained health professional.
Cases of depression were defined as those identified as ever having had an episode of major
depression (single or recurrent). “Depression controls” were those who responded negatively
to both SCID screening questions.
In the TwinsUK cohort, the diagnosis of depression was obtained from the Composite
International Diagnostic Interview (CIDI) questionnaire according to the DSM-IV criteria for
major depression disorder (MDD) and was handled as a dichotomous variable in all analyses
[33].
Cardiovascular parameters. In the GS:SFHS cohort, angina was identified using the
shortened World Health Organisation (WHO) Rose Angina Questionnaire [34], which is used
widely in epidemiological studies as a standardised method for identifying angina and as a risk
assessment tool for ischaemic heart disease [35]. Population-based studies have shown that
individuals with Rose questionnaire angina have an increased risk of incident ischaemic heart
disease and more coronary atherosclerosis [36]. The full version of the questionnaire was
included in the original GS:SFHS questionnaire. We used the shortened Rose Angina Ques-
tionnaire to maximise the availability of complete data (Box 1). This shortened version con-
tains three questions to predict ‘exertional chest pain’ and has been shown to perform better
than the full version at identifying angina in primary care [34].
We also included participants who self-reported having ischaemic heart disease, to detect
those with well-controlled (medicated) angina who might respond negatively to the Rose
Angina questionnaire. Angina was therefore defined by answering ‘Yes’ to question 1 and ‘Yes’
to either question 2 or 3 (Box 1) on the shortened Rose Angina Questionnaire, and/or by
Box 1. Shortened WHO Rose Angina questionnaire focusing on exertional
chest pain (from Lawlor et al.[34]
Q1. Do you ever have any pain or discomfort in your chest? (Yes/No)
Q2. When you walk at an ordinary pace on the level does this produce the pain? (Yes/
No/Unable)
Q3. When you walk uphill or hurry does this produce the pain? (Yes/No/Unable)
Shared genetics links chronic pain, depression and cardiovascular disease
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answering positively to self-reported ischaemic heart disease. Those who responded negatively
to both the shortened Rose Angina questionnaire, and ischaemic heart disease were classified
as “angina controls”.
In TwinsUK, a generic variable as an indicator of cardiovascular health/status was used.
Participants reporting a medical diagnosis of hypertension, angina, stroke, heart attack, ele-
vated cholesterol, or having had an angioplasty or bypass surgery were assigned as having “any
cardiovascular disease (CVD)” (assigned = 1), whereas participants without any such diagnosis
were assigned = 0 (no CVD).
Data analysis
Generation Scotland. Data were analysed using SPSS (version 22; SPSS Inc., Chicago, IL,
USA) and included only those individuals with valid case/control definitions for each of (i)
chronic pain, (ii) major depressive disorder, and (iii) angina, as appropriate for the analysis.
Co-occurrence of depression, angina and chronic pain in GS:SFHS (entire cohort).
Individuals were classified according to pairwise co-occurrence of two conditions (chronic
pain-depression; chronic pain-angina; depression-angina), or co-occurrence of all three condi-
tions. Co-occurrence controls had neither/none of the conditions under examination. We
compared the expected co-occurrence of conditions by chance with the observed co-occur-
rence prevalence. Stepwise logistic regression was carried out to estimate odds ratios (ORs)
with and without adjustment for covariates (age, gender, smoking status, education, depriva-
tion). Covariates with P>01 were removed from analysis. Analysis was also stratified by gen-
der. We tested for homogeneity of ORs between genders (Breslow-Day).
Analyses were conducted for the entire cohort (including related individuals), and for a
subset of unrelated individuals. Unrelated individuals within pedigrees were identified by
selecting the oldest phenotyped family member and removing all biological relatives (e.g. par-
ent, child, sibling, avuncular), then selecting the oldest remaining unrelated, phenotyped pedi-
gree member and repeating this process until only unrelated individuals from within each
pedigree remained.
We conducted sensitivity analysis of participants with chronic pain and angina in order to
assess the confounding effect of angina also being reported as chronic pain, by identifying
those individuals reporting the chest as the main site of chronic pain with angina cases and
repeating the analysis excluding these participants.
Chronic pain, depression and angina amongst GS:SFHS sibling-pairs. Within each
family, full siblings were identified based on reported shared parentage. Where there were more
than two siblings with phenotype data available, two siblings were selected at random (indepen-
dently of all variables included in analyses), and randomly allocated to be “sib1” or “sib2”.
Logistic regression was performed as above, but using as predictor sib1 disease status and
outcome sib2 disease status (with and without adjustment for sib2 covariates), and vice versa,
for all sibling pairs or within same-gender pairs. Sibling recurrence risk ratios [λS] were calcu-
lated from trait prevalence data for the sibling pairs compared with all siblings in the data set
(the eligible general population). Analyses were performed for co-occurrence of the same trait
in siblings or for co-occurrence of different traits in siblings (cross-phenotype analysis). Cross-
phenotype logistic regression was performed with additional adjustment for the same trait in
sib2 as the sib1 predictor trait (e.g. when assessing risk for sib2 of having depression when sib1
has chronic pain, analyses were also adjusted for presence of chronic pain in sib2). Results
were considered significant at p<005.
Twins UK. Analyses were conducted by R statistical software version 3.1.2 [37] with
bivariate genetic analyses conducted using “OpenMx” packages [38]. First, tetrachoric
Shared genetics links chronic pain, depression and cardiovascular disease
PLOS ONE | DOI:10.1371/journal.pone.0170653 February 22, 2017 5 / 19
correlations between CVD, depression, and CWP were calculated. The phenotypic covariance
between CVD and CWP was decomposed into the additive genetic factor (A), non-additive
genetic factor (D) or shared environmental factor (C), and non-shared environmental factor
(E), based on the usual assumptions (i.e. MZ twin pair share all their genes and DZ twin pair
share half their genes) [30, 39]. The phenotypic covariance between the observed variables was
partly decomposed into A and D when the phenotypic covariance in MZ twin pairs was higher
than in those in DZ [30]. When the phenotypic covariance in MZ twin pairs was similar to
those in DZ, the phenotypic covariance was decomposed into C.
To identify the best fitting model, a three-step approach was conducted using structural
equation modelling. First, we compared the full ACE and ADE bivariate Cholesky model with
fully saturated model because C and D could not be estimated in the same model. Fig 1 shows
the full ACE Cholesky model. The variance-covariance matrix in the fully saturated model was
treated as a free parameter that was equal to the sample variance-covariance matrix. Second,
we compared the full ACE or ADE bivariate Cholesky model with the AE bivariate Cholesky
model to test whether liquidation of C or D factors was legitimate. Finally, we explored the
best fitting submodels by eliminating parameters and latent variables and by comparing these
submodels with the full ACE or ADE bivariate Cholesky model. The best fitting model was
determined on the basis of the likelihood ratio test and the lowest AIC (Akaike information
criterion). All phenotypes were controlled for age and body mass index. Standardized coeffi-
cients and 95% confidence intervals (CIs) were obtained. To handle missing data, full-infor-
mation maximum likelihood was used. Under the missing at random assumption, full-
information maximum likelihood was able to provide preferred parameter estimates [40].
Ethics and approval
GS:SFHS received ethical approval for the creation of the resource (05/S1401/89 NHS Tayside
Committee on Medical Research Ethics A) and Research Tissue Bank approval has been granted
Fig 1. Path diagram of the Cholesky model for the covariance between chronic widespread pain
(CWP) and cardiovascular disease (CVD) with adjustment for age.
doi:10.1371/journal.pone.0170653.g001
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providing for use of the data and samples for medical research, including this study (10/S1402/
20 and 15/ES/0040 NHS EoSRES). All participants provided written informed consent.
TwinsUK had received ethical approval from the Westminster ethics committee (07/H0802/
84) and all participants provided written informed consent.
Funding
Generation Scotland has received core funding from the Chief Scientist Office of the Scottish
Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. The
funders had no role in study design, data collection, data analysis, data interpretation, or writ-
ing of the report, or the decision to submit for publication. The corresponding author had
final responsibility for the decision to submit for publication.
TwinsUK: the study was funded by the Wellcome Trust; European Community’s Seventh
Framework Programme (FP7/2007-2013). The study also receives support from the National
Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Bio-
medical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership
with King’s College London.
Results
Characteristics of study population: Generation Scotland
The characteristics of the entire study population, unrelated individuals and sibling pairs are
shown in Table 1. Of the 24,042 participants in the GS:SFHS cohort, the majority were female
Table 1. Characteristics of the overall GS:SFHS, unrelated subset and sibling pairs subset‡.
Overall GS:SFHS Unrelated individuals Sibling pairs
n = 24,042 n = 9,163 n = 11, 740
Age (median, IQR) 49 yr (IQR 36–59) 59 yr (52–65) 47 yr (IQR 36–57)
Gender (female) 14,064 (587%) 5,353 (584%) 7,011 (599%)
Education
Degree, diploma or technical qualification 13,741 (617%) 4,663 (557%) 7,292 (651%)
School leaving 6,043 (271%) 2,287 (273%) 2,873 (256%)
No qualification 2,497 (112%) 1,420 (17%) 1,039 (93%)
Deprivation (SIMD)
1 (most deprived) 2,711 (129%) 1,052 (127%) 1,297 (127%)
2 2,965 (141%) 1,126 (136%) 1,363 (133%)
3 3,417 (163%) 1,307 (158%) 1,666 (163%)
4 5,392 (257%) 2,059 (248%) 2,698 (264%)
5 (least deprived) 6,529 (311%) 2,749 (331%) 3,186 (312%)
Smoking status
Never smoked 12,267 (527%) 4,527 (510%) 6,339 (546%)
Stopped >12 months 6,279 (270%) 2,925 (329%) 2,955 (255%)
Stopped < 12 months 713 (31%) 182 (20%) 351 (30%)
Current smoker 4,013 (172%) 1,249 (141%) 1,963 (169%)
Any chronic pain (CPG I–IV) 7,162 (355%) 3,106 (423%) 3,665 (340%)
Clinically-significant chronic pain (CPG II–IV) 3,664 (181%) 1,641 (279%) 1,755 (198%)
Major depressive disorder (MDD) 2,755 (129%) 960 (128%) 1,513 (150%)
Angina 2,009 (100%) 1,102 (144%) 851 (80%)
‡Percentages (%) is based on valid data; SIMD: Scottish Index of Multiple Deprivation 2009; CPG: chronic pain grade
doi:10.1371/journal.pone.0170653.t001
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(587%). The median age was 49 years (IQR 36–59) and just over one-quarter of the cohort
lived in the two most deprived SIMD quintiles. Compared to the “unrelated” subgroup, the
overall population cohort and sibling-pairs subgroup were most alike across most demo-
graphic characteristics. Those in the “unrelated” group were older, likely due to the method
used to select unrelated individuals.
Chronic pain. In total, 20,199 individuals completed the chronic pain screening ques-
tions. There were 7,162 individuals for whom a CPG was calculated (355%) and 13,037
“chronic pain controls”. Of those for whom the CPG was calculated, 3,498 (173%) were
classed as CPG I; 2,438 (121%) as CPG II; 611 (30%) as CPG III, and 615 (30%) as CPG IV,
making 3,664 (181%) individuals with clinically significant chronic pain (CPG II-IV) who
were classed as “chronic pain cases”.
Depression. Of those who attended the research clinic, 21,380 had valid depression screen-
ing results. Just over one-fifth (n = 4,714) screened positive and were invited to complete the
SCID interview, leaving 16,666 individuals as “depression controls”. Of the screened individu-
als, 842% (n = 3,968) completed the face-to-face clinical interview, where 2,755 individuals
(129%) were identified as “depression cases”. Those with bipolar mood disorder or no history
of major depressive disorder following SCID interview were excluded from further analysis
(n = 1,213).
Angina. Of the 20,115 valid responses to the short Rose angina questionnaire 1,684
(84%) individuals were identified as cases of angina. There were 930 (40%) who volunteered
a history of ischaemic heart disease, 325 of whom had screened negative to the Rose Angina
questionnaire. Thus there were 2,009 “angina cases” (100%) and 18,106 “angina controls”.
Co-occurrence of depression, angina and chronic pain: Generation
Scotland
The co-occurrence of chronic pain and depression (Table 2) was seen in 53%, (714/13,422 of
the GS:SFHS cohort with valid responses); chronic pain and angina 46%, (678/14,616); and
depression and angina 23% (371/16,284). All three conditions co-occurred in 18% of those
with valid responses (169/9,492). All conditions co-occurred more often than expected by
chance: expected frequency of chronic pain and depression co-occurrence 23% vs 53%
observed co-occurrence; chronic pain and depression 18% vs 46%; depression and angina
12% vs 23%.
Subgroup analysis of chronic pain and angina (n = 678) showed that individuals with
angina reported numerous sites of chronic pain. Individuals with angina and chronic pain
reported their most painful body site as follows: pains in arms, hands, legs, hips or feet
(n = 170); back pain (n = 124); neck and shoulder pain (n = 70); chest pain (n = 47). Of the
Table 2. Co-occurrence of chronic pain, major depressive disorder and/or angina in GS:SFHS overall.
Combinations of conditions Presence of conditions 1 Absence of conditions 2 Total
Chronic pain and depression 714 (53%) 9,424 13,422
Chronic pain and angina 678 (46%) 11,058 14,616
Depression and angina 371 (23%) 12,880 16,284
Depression, angina and chronic pain 169 (18%) 8,089 9,492
1Presence of conditions: Chronic pain = Chronic Pain Grade II-IV; Depression = positive after SCID interview as ever having had an episode of major
depressive disorder (single or recurrent); Angina = positive for shortened Rose angina questionnaire or self-reported history of ischaemic heart disease
2 Absence of conditions: Chronic pain = no current pain to screening questions; Depression = negative to both SCID screening questions;
Angina = negative to shortened Rose Angina questionnaire, and no history of ischaemic heart disease.
doi:10.1371/journal.pone.0170653.t002
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latter 47 participants, only 14 reported ‘chronic chest pain’ as their sole location of chronic
pain. Sensitivity analysis excluding those with angina and the chest as their main site of
chronic pain found no alteration in the final results.
Association between chronic pain, depression and angina: Generation
Scotland
Individuals with depression were more than twice as likely to have chronic pain as those without
after adjustment for known confounders (adjusted OR 264 [95% CI 234–297]), while those
with angina were four times more likely to have chronic pain (adjusted OR 419 [364–482])
(Table 3). Individuals with both angina and depression had greater odds of also having chronic
pain (adjusted OR 943 [685–1298]. Female participants had slightly greater ORs than male
participants, but none of the differences were significant (Breslow-Day P>005) (S1 Table).
Reversing the analyses (Table 3), we found that individuals with chronic pain were more
likely to have a history of depression than not (adjusted OR 262 [232–296]) and were more
Table 3. The effect of comorbidity on the occurrence of depression and/or angina in GS:SFHS overall.
Exposure Outcome Unadjusted Adjusted†
N OR [95% CI] N OR [95% CI]
Chronic pain in the presence of depression
Depression Chronic pain 13, 376 280 a 11,679 264a
[252–311] [234–297]
Chronic pain in the presence of angina
Angina Chronic pain 14,564 544 a 11,973 419a
[483–613] [364–482]
Chronic pain in the presence of depression and angina
Depression and angina Chronic pain 9,728 1328 a 8,543 943a
[1002–1759] [685–1298]
Depression in the presence of chronic pain
Chronic Pain Depression 13,376 280a 11,679 262a
[252–311] [232–296]
Depression in the presence of angina
Angina Depression 16,224 218a 14,121 210a
[192–247] [182–243]
Depression in the presence of chronic pain and angina
Chronic pain and angina Depression 9,461 436a 8,297 378 a
[358–530] [299–478]
Angina in the presence of chronic pain
Chronic pain Angina 14,564 545a 11,973 423 a
[484–614] [367–486]
Angina in the presence of depression
Depression Angina 16,224 218a 14,121 220 a
[192–247] [190–254]
Angina in the presence of chronic pain and depression
Chronic pain and depression Angina 9,003 915a 7,919 776 a
[743–1126] [605–995]
†valid data adjusted for age, gender, education, SIMD and smoking status
a
= p<0.001.
doi:10.1371/journal.pone.0170653.t003
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likely to report angina symptoms than not (adjusted OR 423 [367–486]). Similarly, individu-
als with depression were more likely to have angina than not (adjusted OR 220 [190–254]).
Individuals with both depression and chronic pain were much more likely to report angina
symptoms than not (adjusted OR 776 [605–995]). In the presence of chronic pain, female
participants had higher ORs than male participants for depression and angina respectively, but
none of the differences were significant (Breslow-Day P>005) (S2 Table). Results from the
“unrelated” subgroup (S3–S5 Tables) were similar to the larger family-based cohort, indicating
that the associations between chronic pain, depression and angina in the entire cohort were
not due to excess shared familial factors (genetic or environmental) in the family-based study.
Chronic pain, depression and angina amongst sibling-pairs: Generation
Scotland
Sib-pair analysis (S7 Table) produced similar ORs to both the entire cohort and the “unre-
lated” subset for unadjusted and adjusted analyses, and for gender-stratified analysis, suggest-
ing that no bias was introduced during sib selection.
For the same-trait analysis, there was a two-fold increased risk to sib2 for chronic pain
when sib1 had chronic pain (adjusted OR 230 [183–289]). This increased risk for the same
trait was apparent with depression (adjusted OR 216 [173–270]) and angina (adjusted OR
278 [200–386]) (S6 Table). Results were similar with same-gender sib pairs (S8 Table). Con-
sistent with these findings, sibling recurrence risk ratios (λS) significantly exceeded 1 for all
same-trait comparisons, with λS corresponding to odds ratios. For depression, λS = 165;
chronic pain λS = 184; and angina λS = 231 (S6 Table).
In cross-trait analyses, the sib risk was significantly increased in all pairwise comparisons
(pain-depression; angina-pain; depression-angina), with adjusted ORs ranging from 134–219
(Table 4). ORs were unaffected or only slightly attenuated after adjustment; and were largely
similar for same-gender sib pairs, although p values attenuated owing to reduced sample size
Table 4. Unadjusted and adjusted ORs for cross-trait analysis of angina, depression and chronic pain amongst sibling-pairs in GS:SFHS.
Exposure (Sib1 status) Outcome (Sib2 status) Unadjusted Adjusted Also adjusted for sib1
trait in sib2
λS
N OR [95% CI] N OR [95% CI] N OR [95% CI]
Angina Chronic pain 4,014 261 3,275 219 3,006 166 183
[203–337] *** [163–295] *** [119–233] ** [156–215] *
Angina Depression 4,595 152 3,967 148 3,581 145 135
[116–199] ** [109–201] ** [104–202] * [109–166] *
Chronic pain Angina 4,026 248 3,280 201 2,530 199 171
[193–319] *** [149–271] *** [138–286] *** [142–207] *
Chronic pain Depression 3,831 184 3,295 169 2,504 171 143
[150–226] *** [134–214] *** [128–228] *** [124–166] *
Depression Angina 4,562 197 3,757 198 3,414 196 170
[154–254] *** [149–265] *** [144–267] *** [139–208] *
Depression Chronic pain 3,796 130 3,124 134 2,842 131 124
[105–161] * [105–171] * [100–170] * [106–144] *
λS = sibling recurrence risk ratio
*p0.05
** p0.01 &
*** p 0.001
doi:10.1371/journal.pone.0170653.t004
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(S9 Table). Additional adjustment for the same trait in sib2 as present for sib1 had little effects
on the results, indicating that the increased risk to sib2 was not attributable to presence of the
same trait as present for sib1. This finding suggests that the increased risk was instead due to
presence of a common risk factor for both disorders. Cross-trait λS also significantly exceeded
1 for all pairwise comparisons, ranging from 124 (depression-chronic pain) to 183 (angina-
chronic pain), consistent with shared familial risk factors in these disorders.
Characteristics of study population: TwinsUK
Table 5 summarises the main characteristics of the TwinsUK cohort. The mean age was 56
years old (SD 1397). The proportion of participants with chronic pain was 20%, 223% had
depression and 347% reported any cardiovascular disease. No significant association between
depression and cardiovascular disease could be detected, whereas chronic pain showed a sig-
nificant correlation with depression (r = .34) and cardiovascular disease (r = .26; Table 6).
Interclass correlation and cross-twin cross-trait correlation: TwinsUK
The intraclass correlations were consistently higher in MZ compared to DZ twin pairs across
all three phenotypes (Table 7). Furthermore, significant cross-trait cross-twin correlation
could be detected in the MZ twins but not in the DZ twins.
Bivariate Cholesky model: Twins UK
We were unable to obtain well-fitting models for the trivariate analysis. Thus having published
already on the relationship between chronic pain and depression [41], we concentrated on the
bivariate analysis of chronic pain and cardiovascular disease. In the saturated models, the
mean and variance of all phenotype were equal across twin order and zygosity, so met the
requirement for bivariate Cholesky models. On the basis of the AIC, the ACE Cholesky model
was considered to be the best fitting model (Table 8). Dropping C resulted in an even better
model fit (S10 Table), suggesting that common genetic factors and independent non-shared
Table 5. Study characteristics of the n = 2,902 twins from the TwinsUK cohort.
Overall (n = 2,902) MZ (n = 1,498) DZ (n = 1,404)
Age, mean (SD), range 56 yr (13.97), 18–89 55 yr (14.92), 18–86 57 yr (12.79), 20–89
BMI, mean (SD), range 25 (4.5), 15–53 25 (4.46),15–53 25 (4.54), 15–48
Cardiovascular disease, n (%) 1,006 (34.7%) 473 (31.6%) 533 (38.0%)
Depression, n (%) 646 (22.3%) 341 (22.8%) 305 (21.7%)
Chronic pain±, n (%) 579 (20.0%) 265 (17.7%) 314 (22.4%)
MZ, monozygotic; DZ, dizygotic; SD, standard deviation; BMI, body mass index; ±chronic widespread pain
doi:10.1371/journal.pone.0170653.t005
Table 6. Phenotypic correlations (r) with [95% confidence intervals] between observed variables in TwinsUK (n = 2,902).
Depression CVD CWP
Depression 1
Cardiovascular disease 0.04 [-0.01–0.08] 1
Chronic pain± 0.34 [0.30–0.37] 0.26 [0.23–0.29] 1
±chronic widespread pain.
doi:10.1371/journal.pone.0170653.t006
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environmental factors contribute to the covariation in chronic pain and cardiovascular disease
(S10 Table and Fig 1).
Discussion
This is the first, large-scale study to examine the three important traits of chronic pain, cardio-
vascular disease and depression, where the findings have been reproduced to some extent in a
second, independent population sample. While a genetic component has long been recognised
in each of the three conditions individually, it has been thought that social risk factors such as
poverty and deprivation were likely to underlie their co-occurrence. To our surprise, even
adjusting for socio-economic status and other environmental risk factors, we found significant
odds ratios for co-occurrence. This led us to model chronic pain and cardiovascular disease in
twins, and to show a small but significant shared genetic predisposition.
We have shown that three common long-term conditions: chronic pain, cardiovascular disease
and/or depression cluster together in two epidemiologically unbiased samples. Our family-based
study brings new insight into the contribution of shared familial factors to this co-occurrence,
showing that this association clearly navigates across conditions within sibling-pairs: the presence
of one condition increases the risk of other conditions occurring, both in an individual and in his/
her family members. Together with the results from the twins’ analysis, this supports the notion
that shared, genetically mediated aetiological pathways contribute to the co-morbidity of common
chronic conditions.
A number of common biological pathways have already been implicated in development of
depression, chronic pain or cardiovascular disease in experimental models of disease and in
human studies. These include the endocannabinoid system, hypothalamic-pituitary-adrenal
(HPA) axis, and inflammation. Genetic modification of the endocannabinoid system leads to
Table 7. Intraclass correlations and cross twin trait correlations [95% confidence interval] in Twins
UK.
MZ DZ
Cross-twin/within trait
Depression 0.51 [0.44–0.58] 0.20 [0.11–0.3]
Cardiovascular disease 0.75 [0.72–0.78] 0.51 [0.46–0.57]
Chronic pain± 0.73 [0.69–0.76] 0.46 [0.39–0.51]
Cross-twin/cross-trait
Depression/Cardiovascular disease 0.12 [0.03–0.20] -0.02 [-0.11–0.07]
Depression/Chronic pain± 0.22 [0.14–0.30] 0.19 [0.10–0.28]
Cardiovascular disease/Chronic pain± 0.27 [0.20–0.34] 0.16 [0.09–0.23]
±chronic widespread pain; MZ, monozygotic; DZ, dizygotic.
doi:10.1371/journal.pone.0170653.t007
Table 8. Model comparison between the full saturated, the full ACE Cholesky, and the full ADE Cholesky models for chronic pain± and cardiovas-
cular disease (n = 2,902): Twins UK.
Difference of log likelihood Difference of degree of freedom P-value AIC BIC
Full saturated model Base Base NA -5906.552 -36361.64
Full ACE Cholesky model 37.14781 25 0.06 -5919.404 -36506.49
Full ADE Cholesky model 42.37443 25 0.02 -5914.177 -36501.26
A, additive genetic factors; C, shared environmental factors; E, nonshared environmental factors; D, non-additive genetic factors
±chronic widespread pain; AIC, Akaike information criterion; BIC, Schwarz’s Bayesian information criteria; NA, not applicable.
doi:10.1371/journal.pone.0170653.t008
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age-related ventricular dysfunction [42], while genetic variants in cannabinoid and/or adren-
ergic pathway components have been implicated in chronic pain conditions [43, 44]. Brain
expression of endocannabinoid-related genes are altered in response to early life stress [45],
and this system may act to sensitise excitatory neurotransmission [46]. HPA axis dysfunction
in offspring as a result of maternal stress during pregnancy has also been described [47] as well
as early life stress [48, 49]. Inflammatory pathways have also been implicated in development
of depression [50], chronic pain [51], and cardiovascular disease [52], in particular the concept
that adverse environmental factors (including early life stress) might transmit a biological sig-
nal via altered allostatic load, leading to multimorbidity in adulthood (including chronic pain,
mental health and cardiovascular conditions) [53]. However, whether these are epiphenomena
versus causal remains unclear [51, 54] but new techniques such as Mendelian randomisation
are allowing direction of causation to be determined, such as the adrenal hormone abnormali-
ties appearing secondary to CWP [55]. A genetic liability for all three disorders is widely
reported, and may also explain the familial component to co-occurrence of these three traits;
identification of a shared genetic predisposition and assessment of whether these are shared
across multiple disorders is required.
There are limitations to the study to be aware of when interpreting our findings. First, diag-
nosis of “cardiovascular disease” in both datasets relied on self-reported data and/or question-
naire using well-validated instruments [24, 32]. Specifically in TwinsUK, this was relatively
non-specific and included a number of risk factors such as hypercholesterolaemia. This would
have served, however, to weaken our findings rather than strengthen them, so it is all the more
surprising that a shared genetic influence was detected between cardiovascular disease and
chronic pain. The small number of males with chronic pain and CVD data in TwinsUK meant
that only females could be considered; however, the large population-based Generation Scot-
land cohort shows that the relationship between the traits is seen both in men and in women.
We recognise that there are differences in phenotyping, data collection, case definitions and
measures used between the two studies, and this is a limitation of aligning two distinct but com-
plimentary studies. In particular, the definitions of cardiovascular disease differed between GS:
SFHS and TwinsUK, and comparison between the cohorts can only be approximate in this phe-
notype. However, the phenotyping is similar enough to allow comparison between these two
population-based studies. The handling of covariates is a limitation, with BMI not included in
GS, and with modelling in TwinsUK not allowing for inclusion of covariates such as smoking
or education; alignment of the two cohorts is therefore incomplete.
We had no means of identifying people who had a history of chronic pain but who were
not currently affected, and these would have been included as controls. However, clinical expe-
rience suggests that the proportion of patients who have chronic pain and get better is very
small indeed. We did not distinguish past major depression from that which was current.
Nonetheless it seems that depression in “remission”, i.e. a history of major depressive disorder,
still confers a significant risk of developing the linked condition e.g. chronic pain [56, 57]. As
with all cross-sectional studies, the directional relationships between these three conditions
cannot be determined, pointing to the need for longitudinal studies. Similarly, the relationship
with other chronic diseases co-morbid with these conditions (e.g. type 2 diabetes) was not
explored.
Information on specific medications taken by individuals to manage each condition in our
datasets were not available. Potentially this could lead to under-reporting of a condition (e.g.
chronic pain) which is well controlled by medications. Any future study should aim to corre-
late self-reported angina, chronic pain and depression with electronic health records and rele-
vant prescribed medication. While medication can reduce the severity and impact of chronic
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pain or angina, it is unlikely to remove it–the diagnosis is therefore still likely to be self-
reported, though its reported severity may be less than were it untreated.
The possibility that some other shared environment not included in our model and not cap-
tured by current deprivation status has confounded the results, is made considerably less likely
by the results from the twin study. We have already reported a shared genetic influence on the
risk of chronic pain and depression in TwinsUK [41]. The twin sample size limited our ability
to perform three-way analysis.
Clinically, depression and cardiovascular disease are well-known co-morbidities [58], prompt-
ing routine screening in primary care cardiovascular clinics [59]. The demonstration that the
presence of chronic pain may increase the likelihood of depression and/or cardiovascular disease
has further implications for clinical practice, not least because it is more prevalent than both
depression (9%) or ischaemic heart disease (83%)[60]. The reported chronic pain prevalence
across Europe is around 20% [3], and another study in the UK suggests this is around 24% (CPG
II-IV) [61]. That almost a quarter of the UK population manifest this important risk factor for
cardiovascular disease and depression should prompt further screening in patients and their fam-
ily members.
These results have far-reaching implications for targeted management and prevention, and
for prognosis. Might effective treatment of one condition ameliorate a co-occurring, linked con-
dition? Future clinical trials might, very cost-effectively, explore whether optimising depression
therapy in chronic pain leads to improved outcomes [62], and this could extend to family mem-
bers. Early recognition of these conditions will facilitate trials of prevention and also the poten-
tial for addressing these conditions by targeting the common underlying causes (e.g. stress,
health inequalities) rather than symptoms unique to each condition.
Conclusion
We have shown that chronic pain, cardiovascular disease, and depression coexist in individu-
als and across families even after adjusting for known environmental risk factors. The presence
of one trait significantly increases the risk of manifesting another, both in siblings and twins.
Pairs of traits offer even higher risks of manifesting the third. Twin modelling shows that pairs
of traits have shared genetic predisposition which would account for their co-occurrence.
Future work should aim to identify the genetic variants involved, as better understanding of
the biological pathways will clarify the underlying pathogenetic mechanisms as well as having
the potential to provide novel targets for intervention.
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